NCT02585674 - Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo | Biotech Hunter

Enrollment

151

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Insulin glargine (U300)

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DEVICE

MyStar DoseCoach

Glucose meter

Trial Locations (19)

10115

Investigational Site Number 276002, Berlin

23758

Investigational Site Number 276004, Oldenburg in Holstein

24534

Investigational Site Number 276005, Neumünster

45359

Investigational Site Number 276007, Essen

69115

Investigational Site Number 276003, Heidelberg

92237

Investigational Site Number 276008, Sulzbach-Rosenberg

94550

Investigational Site Number 276010, Künzing

01307

Investigational Site Number 276001, Dresden

01796

Investigational Site Number 276006, Pirna

ML6 OJS

Investigational Site Number 826003, Airdrie

BT12 6BA

Investigational Site Number 826002, Belfast

BS10 5NB

Investigational Site Number 826011, Bristol

CH2 1UL

Investigational Site Number 826001, Chester

DG1 4AP

Investigational Site Number 826006, Dumfries

G75 8RG

Investigational Site Number 826008, East Kilbride

FK5 4WR

Investigational Site Number 826005, Larbert

BT47 6SB

Investigational Site Number 826010, Londonderry

SA6 6NL

Investigational Site Number 826009, Swansea

TA1 5DA

Investigational Site Number 826007, Taunton